World Asset Management’s Sage Therapeutics SAGE Stock Holding History

World Asset Management’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,695	Closed	-$238K	–	1138
2019 Q3	$238K	Buy	1,695 +43	+3%	+$7.19K	0.01%	940
2019 Q2	$302K	Buy	1,652 +28	+2%	+$4.78K	0.01%	847
2019 Q1	$258K	Buy	+1,624	New	+$235K	0.01%	923
2018 Q4	–	Sell	-1,621	Closed	-$229K	–	1194
2018 Q3	$229K	Buy	1,621 +10	+0.6%	+$1.54K	0.01%	1092
2018 Q2	$252K	Buy	+1,611	New	+$253K	0.01%	1047
2018 Q1	–	Sell	-1,437	Closed	-$237K	–	1422
2017 Q4	$237K	Buy	+1,437	New	+$139K	0.01%	1265

Other funds holding SAGE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

World Asset Management's SAGE Position: Q4 2019 in Review

World Asset Management sold out of Sage Therapeutics (SAGE) in Q4 2019, closing a stake of 1,695 shares — an estimated $238K sold.

World Asset Management first reported a position in SAGE in Q4 2017 and held it in 6 quarters. The position peaked at $302K in Q2 2019. 267 funds tracked by Wall St. Rank hold SAGE as of Q4 2019.

World Asset Management reported no remaining Sage Therapeutics position as of Q4 2019 after selling out during the quarter.
World Asset Management sold 1,695 Sage Therapeutics shares in Q4 2019, an estimated $238K.
World Asset Management first reported a position in Sage Therapeutics in Q4 2017 and held it in 6 quarters.
World Asset Management's Sage Therapeutics position peaked at $302K in Q2 2019.
267 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2019.

Based on World Asset Management's 13F filing for Q4 2019, filed 28 Jan 2020.